Press release
Liver Cancer Market was valued at USD 8.9 billion in 2024 and is projected to reach USD 15.7 billion by 2034
Liver Cancer Market
The Liver Cancer Market was valued at USD 8.9 billion in 2024 and is projected to reach USD 15.7 billion by 2034, growing at a CAGR of around 5.9%. Growth is driven by rising global incidence of hepatocellular carcinoma (HCC), increased adoption of immunotherapy, and advancements in screening and diagnostic imaging.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71232
Key Market Drivers
• Increasing cases of HCC linked to hepatitis B/C, alcohol use, NAFLD, and metabolic disorders.
• Expanding use of immunotherapies (PD-1/PD-L1 inhibitors) and targeted therapies.
• Improved screening programs using ultrasound, AFP testing, CT, and MRI.
• Growing investment in oncology R&D and combination therapy trials.
Challenges
• Late-stage diagnosis limits the effectiveness of treatment.
• High treatment cost, especially for immunotherapies.
• Limited availability of liver transplantation in most regions.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/71232/liver-cancer-market
Market Segmentation
By Treatment
• Immunotherapy
• Targeted therapy (TKIs, VEGF inhibitors)
• Chemotherapy
• Radiation therapy
• Surgical resection / liver transplantation
• Ablation and embolization therapies
By Cancer Type
• Hepatocellular carcinoma (HCC) - majority share
• Cholangiocarcinoma
• Other rare liver tumors
By Diagnosis
• Imaging (CT, MRI, Ultrasound)
• Liver biopsy
• Biomarker testing (AFP, others)
By End User
• Hospitals
• Cancer specialty centers
• Diagnostic imaging centers
By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71232
Regional Snapshot
• Asia-Pacific leads due to high hepatitis-related liver cancer burden (China, Japan, South Korea).
• North America grows steadily with strong immunotherapy adoption and advanced oncology networks.
• Europe benefits from screening programs and early-access treatment pathways.
Key Companies
Roche, Bristol Myers Squibb, Merck & Co., Novartis, Eli Lilly, Bayer, AstraZeneca, Pfizer.
Future Outlook
Growth will accelerate as combination immunotherapies, precision oncology, and improved screening tools become standard. Increasing focus on early detection, novel targeted agents, and minimally invasive treatments will reshape liver cancer management over the next decade.
This report is also available in the following languages : Japanese (肝臓がん市場), Korean (간암 시장), Chinese (肝癌市场), French (Marché du cancer du foie), German (Leberkrebsmarkt), and Italian (Mercato del cancro al fegato), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71232
Our More Reports:
Spina Bifida In-Utero Market
https://exactitudeconsultancy.com/reports/70965/spina-bifida-in-utero-market
Temporomandibular Disorders Market
https://exactitudeconsultancy.com/reports/70967/temporomandibular-disorders-market
Dermal Regeneration Matrix Market
https://exactitudeconsultancy.com/reports/70969/dermal-regeneration-matrix-market
Internal Trauma Fixation Devices Market
https://exactitudeconsultancy.com/reports/70971/internal-trauma-fixation-devices-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liver Cancer Market was valued at USD 8.9 billion in 2024 and is projected to reach USD 15.7 billion by 2034 here
News-ID: 4311664 • Views: …
More Releases from Exactitude Consultancy
Restless Leg Syndrome (RLS) Market is projected to reach USD 2.62 billion by 203 …
The global Restless Leg Syndrome (RLS) Market was valued at USD 1.47 billion in 2024 and is projected to reach USD 2.62 billion by 2034, growing at a CAGR of 6.0% during 2025-2034. Market growth is driven by rising diagnosis of sleep-related movement disorders, greater clinical awareness of RLS in primary care and neurology, increasing elderly population, and expanding use of dopaminergic agents, α2-δ ligands, and iron-replacement therapies.
Download Full PDF…
Plasmodium vivax Malaria Market is projected to reach USD 2.14 billion by 2034
The global Plasmodium vivax (P. vivax) Malaria Market was valued at USD 1.21 billion in 2024 and is projected to reach USD 2.14 billion by 2034, growing at a CAGR of 6.0% during 2025-2034. Growth is driven by increasing disease surveillance in endemic regions, expanding access to radical cure therapies, rising investment in malaria elimination programs, and ongoing R&D in anti-relapse drugs and vaccines.
Download Full PDF Sample Copy of Market…
Leiomyosarcoma Market Growing at a CAGR of around 6.3%
Leiomyosarcoma Market
The Leiomyosarcoma Market was valued at ~USD 1.05 billion in 2024 and is projected to reach ~USD 1.92 billion by 2034, growing at a CAGR of around 6.3%. Growth is driven by rising incidence of soft tissue sarcomas, improved diagnostic imaging, and wider use of targeted and combination oncology therapies.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71230
Key Market Drivers
• Growing detection of uterine and non-uterine leiomyosarcoma through improved…
Kaposi's Sarcoma Market Growing at a CAGR of around 6.3%
Kaposi's Sarcoma Market
The Kaposi's Sarcoma Market was valued at USD 980 million in 2024 and is projected to reach USD 1.82 billion by 2034, growing at a CAGR of around 6.3%. Growth is supported by rising HIV-associated cases in developing regions, better oncology care access, and expanded use of chemotherapeutic and immunomodulatory treatments.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71228
Key Market Drivers
• Continued prevalence of HIV/AIDS, especially in low-…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
